Market Research Logo

Arbutus Biopharma Corp (ABUS) - Financial and Strategic SWOT Analysis Review

Arbutus Biopharma Corp (ABUS) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Arbutus Biopharma Corp (Arbutus Biopharma), formerly Tekmira Pharmaceuticals Corporation, is a biopharmaceutical company that focuses on the discovery, development and commercialization of proprietary drugs and drug delivery systems indicated for the treatment of chronic hepatitis B infection. Its pipeline includes HBV candidates such as ARB-1467 for HBsAg expression in patients chronically infected with HBV; AB-452 (HBV RNA destabilizer); and capsid assembly inhibitor (AB-423 and AB-506). The company also has cancer, anti-viral and metabolic programs. Arbutus Biopharma develops product candidates based on its lipid nanoparticle (LNP) delivery technology. It has operational presence in the US and Canada. Arbutus Biopharma is headquartered in British Columbia, Canada.

Arbutus Biopharma Corp Key Recent Developments

Aug 28,2018: Arbutus to Participate at the 2018 B. Riley FBR Healthcare Conference
Aug 02,2018: Arbutus reports 2018 second quarter financial results and provides corporate update
Jul 10,2018: Arbutus Presents Corporate Update on Key Milestones
Jun 07,2018: Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer
May 03,2018: Arbutus Announces Corporate Update and First Quarter 2018 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Arbutus Biopharma Corp - Key Facts
Arbutus Biopharma Corp - Key Employees
Arbutus Biopharma Corp - Key Employee Biographies
Arbutus Biopharma Corp - Major Products and Services
Arbutus Biopharma Corp - History
Arbutus Biopharma Corp - Company Statement
Arbutus Biopharma Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Arbutus Biopharma Corp - Business Description
Arbutus Biopharma Corp - Corporate Strategy
Arbutus Biopharma Corp - SWOT Analysis
SWOT Analysis - Overview
Arbutus Biopharma Corp - Strengths
Arbutus Biopharma Corp - Weaknesses
Arbutus Biopharma Corp - Opportunities
Arbutus Biopharma Corp - Threats
Arbutus Biopharma Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Arbutus Biopharma Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 02, 2018: Arbutus reports 2018 second quarter financial results and provides corporate update
Jul 10, 2018: Arbutus Presents Corporate Update on Key Milestones
Jun 07, 2018: Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer
May 03, 2018: Arbutus Announces Corporate Update and First Quarter 2018 Financial Results
Apr 12, 2018: Arbutus Presents Complementary Results From Preclinical Combination Studies of HBV Therapeutic Candidates at EASL 2018
Apr 11, 2018: Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA Therapeutics for Genetic Diseases
Mar 28, 2018: Arbutus to Present HBV Data at 2018 EASL Liver Meeting
Mar 14, 2018: Arbutus Announces Corporate Update and Year-End 2017 Financial Results
Feb 22, 2018: Arbutus Settles Litigation, Terminating Acuitas’ Rights to LNP Technology
Feb 08, 2018: Arbutus Consolidates HBV Business Around Warminster, PA Site
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Arbutus Biopharma Corp, Key Facts
Arbutus Biopharma Corp, Key Employees
Arbutus Biopharma Corp, Key Employee Biographies
Arbutus Biopharma Corp, Major Products and Services
Arbutus Biopharma Corp, History
Arbutus Biopharma Corp, Subsidiaries
Arbutus Biopharma Corp, Key Competitors
Arbutus Biopharma Corp, Ratios based on current share price
Arbutus Biopharma Corp, Annual Ratios
Arbutus Biopharma Corp, Annual Ratios (Cont...1)
Arbutus Biopharma Corp, Interim Ratios
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Arbutus Biopharma Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Arbutus Biopharma Corp, Performance Chart (2013 - 2017)
Arbutus Biopharma Corp, Ratio Charts
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report